Altogether, these results further consolidate a novel mechanism that deubiquitinase USP39 and E3 ligase TRIM26 function in an antagonistic pattern, but not a competitive pattern, and play key roles in controlling ZEB1 stability to determine the HCC progression. Here, USP39 is linked to hepatocellular carcinoma.